Cancer BiologyEndocrinologyPeer-reviewed
Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast Cancer
Shaymaa Bahnassy, Hillary Stires, Jin Lu…·Rebecca Baab Riggins
The paper develops two in vitro models of endocrine therapy-resistant HER2+/ER+ breast cancer and identifies lipid metabolism and ferroptosis as therapeutic vulnerabilities.
11 citations